Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001737953-24-000013
Filing Date
2024-08-08
Accepted
2024-08-08 08:06:36
Documents
84
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q repl-20240630.htm   iXBRL 10-Q 1288599
2 EX-31.1 repl-6302024x10qxex311.htm EX-31.1 10998
3 EX-31.2 repl-6302024x10qxex312.htm EX-31.2 10733
4 EX-32.1 repl-6302024x10qxex321.htm EX-32.1 5172
5 EX-32.2 repl-6302024x10qxex322.htm EX-32.2 5183
  Complete submission text file 0001737953-24-000013.txt   6992781

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT repl-20240630.xsd EX-101.SCH 58306
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT repl-20240630_cal.xml EX-101.CAL 88704
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT repl-20240630_def.xml EX-101.DEF 210355
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT repl-20240630_lab.xml EX-101.LAB 687803
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT repl-20240630_pre.xml EX-101.PRE 467795
87 EXTRACTED XBRL INSTANCE DOCUMENT repl-20240630_htm.xml XML 814471
Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Filer) CIK: 0001737953 (see all company filings)

EIN.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-38596 | Film No.: 241186176
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)